CEACAM based antibacterial agents
OwnerGal Markelinventor
Life of this patent
Estimating the term…
Abstract
Prophylactic and/or therapeutic antipathogen agents are provided that disrupt or prevent the formation of at least one homotypic and/or heterotypic protein-protein interaction that has at least one CEA-family protein and that is involved in the establishment and colonization of a pathogen in a suitable host.
Claims3
A multimer therapeutic agent consisting of two or more different isolated peptides selected from the group consisting of SEQ ID No. 21-SEQ ID No. 24.
A multimer therapeutic agent consisting of the isolated peptides NRQIV (SEQ ID No. 21), NRQII (SEQ ID No. 22), and QNDTG (SEQ ID No. 23).
A multimer therapeutic agent consisting of the isolated peptides NRQIV (SEQ ID No. 21), NRQII (SEQ ID No. 22), and GYSWYK (SEQ ID. No. 24).
Dependencies are inferred from the claim text.